Occlusive Spasm of the Left Anterior Descending Artery and First Diagonal Branch After Implantation of Everolimus Eluting Stents Without Re-stenosis in a Female Patient with Resting Angina

Occlusive Spasm of the Left Anterior Descending Artery and First Diagonal Branch After Implantation of Everolimus Eluting Stents Without Re-stenosis in a Female Patient with Resting Angina

Bibliographic Details
Main Authors:	Giancarlo Pirozzolo, Anastasios Athanasiadis, Udo Sechtem, Peter Ong
Format:	Article
Language:	English
Published:	Compuscript 2017-05-01
Series:	Cardiovascular Innovations and Applications
Online Access:	http://www.ingentaconnect.com/content/cscript/cvia/2017/00000002/00000003/art00009

Similar Items

Persisting Angina after Successful Surgical Removal of a Large Coronary Artery Aneurysm Attached to the Proximal Portion of the Left Circumflex Artery: Role of Coronary Artery Spasm
by: Bahar Sayin, et al.
Published: (2018-07-01)

Repurposing Riociguat for Treatment of Refractory Angina Resulting From Coronary Spasm
by: Valeria Martínez Pereyra, MS, et al.
Published: (2021-03-01)

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)

Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging
by: Mohammad Abdallah Eltahlawi, et al.
Published: (2020-10-01)

Everolimus-eluting stents in interventional cardiology
by: Townsend JC, et al.
Published: (2012-06-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-07-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-01-01)

Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011-07-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
by: Matthijs A Velders, et al.
Published: (2014-01-01)

Clinical and angiographic outcomes at more than 1 year after treatment of chronic total occlusions with the everolimus-eluting bioresorbable vascular scaffold
by: Aylin Hatice Yamac, et al.
Published: (2016-12-01)

Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
by: MohammadSadegh Parsaee, et al.
Published: (2015-10-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Study to assess clinical outcomes of an everolimus-eluting stent (EES) versus a sirolimus-eluting stent (SES)
by: Amit Madaan, et al.
Published: (2015-12-01)

Paclitaxel-eluting stent (PES) versus everolimus-eluting stent (EES) in insulin requiring diabetics – Are the results different?
by: U. Kaul, et al.
Published: (2015-12-01)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents.
by: Matthijs A. Velders, et al.
Published: (2013-01-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity
by: Astrid Hubert, et al.
Published: (2020-03-01)

Twelve-month comparative analysis of clinical outcomes using biodegradable polymer–coated everolimus-eluting stents versus durable polymer–coated everolimus-eluting stents in all-comer patients
by: Atul Abhyankar, et al.
Published: (2019-03-01)

Treatment of Coronary Spastic Angina, Particularly Medically Refractory Coronary Spasm
by: Hiroki Teragawa, et al.
Published: (2008-01-01)

One-Year Outcome of Everolimus-Eluting Stents versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2016-10-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
by: Imad Sheiban, et al.
Published: (2008-02-01)

Paclitaxel-eluting versus everolimus-eluting stents in patients with diabetes mellitus and coronary artery disease (TUXEDO India Study)
by: U. Kaul, et al.
Published: (2015-12-01)

Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4
by: Mehriar Shokri, et al.
Published: (2015-12-01)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
by: Panoulas VF, et al.
Published: (2015-07-01)

Interleukin-6 kinetics can be useful for early treatment monitoring of severe bacterial sepsis and septic shock
by: Thomas Klag, et al.
Published: (2016-03-01)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
by: Saurabhi Samant, et al.
Published: (2021-04-01)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
by: Sanchez OD, et al.
Published: (2014-12-01)

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
by: Bennett J, et al.
Published: (2013-06-01)

Comparison of everolimus-eluting and sirolimus-eluting coronary stents in 1-year clinical and angiographic follow-up: A retrospective cohort study
by: Ankur Gupta, et al.
Published: (2015-12-01)

First Diagonal Coronary Artery: Left Ventricular Fistula Presenting as Unstable Angina
by: Murat Sener, et al.
Published: (2013-01-01)

A Challenging Case of Bifurcation Lesion in Left Anterior Descending Artery: Managed Successfully with Everolimus-Eluting Bioresorbable Vascular Scaffold and Kissing Balloon Technique under Optical Coherence Tomography Guidance
by: Sridhar Kasturi, et al.
Published: (2015-01-01)

Spontaneous Left Main and Right Coronary Artery Spasm in a Patient With Vasospastic Angina
by: Analkumar Parikh MD, et al.
Published: (2017-09-01)

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
by: Jerin M, et al.
Published: (2012-04-01)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction.
by: Yongcheol Kim, et al.
Published: (2020-01-01)

Long‐term (beyond 5 years) clinical impact of Xience everolimus‐eluting stent implantation
by: Hiroaki Matsuda, et al.
Published: (2021-09-01)